FDA Inspection 1103042 — Siegfried (Nantong) Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Siegfried (Nantong) Pharmaceuticals Co., Ltd. on August 16, 2019 in Nantong. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 16, 2019
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Nantong (China)